Finny logo
Finny logo
Dibs:
Dibs:
0

Tandem Diabetes (TNDM) stock: is there any upside?

10:23 am ET, 05 Oct 2018

Tandem Diabetes Care, Inc. (TNDM) shares are trading at $36.18, up 3%.  The Tandem stock lost 30% of its value since its recent peak of $51 on September 13. What's driving TNDM stock price? What's TNDM stock price forecast?

Tandem Diabetes Care is a medical device company and manufacturer of touch screen insulin pumps. The stock has yielded a remarkable return of 1,927% in the past year. Tandem has recently updated its yearly revenue guidance from $140 million to $148 million to $150 million to $158 million. 

Investors are bullish on the stock because of the success of t:slim X2 insulin pump. On the other hand, some investors feel the stock upside is limited now. The last quarter’s revenue grew 60% to $34.13 million and earnings per share came at -$1.17 compared to -$4.36 for the same period last year.

The third-quarter results will be released after market close on October 29, 2018.  Analysts expect the company to report a loss of -$0.33 per share on revenue of $35.42 million.  Management has since raised revenue guidance to $42-44 million. The company beat analyst revenue estimates in the previous three quarters but missed EPS estimates twice. 

What is the sentiment towards the TNDM stock? Our technical analysis shows that: 

  • The stock short-term sentiment (next 30 days) is trending positive;
  • The mid-term sentiment (3-6 months) is trending positive;
  • The long-term sentiment (9-12 months) is trending positive. 

Over the last month, Tandem Diabetes Care, Inc. (TNDM) returned +21.4%.

Tandem Diabetes Care, Inc. (TNDM) short share of float is 12.56%. The stock is much more frequently shorted than the average industry, sector or S&P 500 stock.

Tandem Diabetes Care, Inc. (TNDM) average analyst price target ($41.56) is -4.72% below its current price ($43.62).

For the latest price and information on Tandem Diabetes Care, Inc., please visit Finstead and search for "TNDM price" or "TNDM news".

Tandem Diabetes Care (TNDM) is soaring: will this last?

9:26 pm ET, 21 Jun 2018

Tandem Diabetes Care, Inc. (TNDM) shares are trading at 24.90, up  21% from yesterday. What's causing the big spike and what's the stock forecast? 

Tandem Diabetes Care announced today FDA's approval of the t:slim X2 Insulin Pump with Basal-IQ technology, a predictive low glucose suspend (PLGS) feature designed to help reduce the frequency and duration of low glucose events (hypoglycemia). 

The company plans to launch its new product with a continuous glucose monitoring integration, which requires no fingersticks for calibration or diabetes treatment decisions.  Tandem expects the t:slim X2 Pump with Basal-IQ technology to be available in August 2018.  All in-warranty t:slim X2 users in the United States will have the option to add the new feature free of charge via remote software update.

Over the last month, Tandem Diabetes Care, Inc. (TNDM) returned +65.26%.

Tandem Diabetes Care, Inc. (TNDM) short share of float is 6.22%. The stock is much more frequently shorted than the average industry, sector or S&P 500 stock.

Tandem Diabetes Care, Inc. (TNDM) average analyst price target ($11.42) is -43.77% below its current price ($20.31).

Tandem Diabetes Care is a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States. Use of the t:slim X2 Pump with Basal-IQ technology in the pivotal clinical study demonstrated a 31 percent relative reduction in time spent below 70 mg/dL, with no rebound hyperglycemia compared to a continuous-glucose-monitoring-enabled insulin pump without the feature.

For the latest price and information on Tandem Diabetes Care, Inc., please visit Finstead and search for "TNDM price" or "TNDM news".

Tandem Diabetes Care, Inc. (TNDM) Stock Guide

Updated at: 5:16 pm ET, 18 Sep 2020

Before we start: if you're looking for TNDM stock price, you can quickly find it out by visiting Finny and typing "TNDM quote". If you're looking for a quick scoop on TNDM stock (chart, price target, market cap, news and buy or sell analysis), go to Finny and look for "TNDM". You'll get all this info in one place. Or you can just type "TNDM news" to get the latest stock news.

Looking to buy or sell Tandem Diabetes Care, Inc. (TNDM)? Interested in getting the full scoop on TNDM, including earnings and dividends, stock forecast, buy or sell analysis and key stats? If so, you came to the right place.

In this TNDM stock guide, we'll address key questions about TNDM, above and beyond what you can find on Yahoo Finance, Zacks, MarketWatch or Morningstar.

Here is what you'll be able to find in this guide:

Earnings and Dividends: earnings, earnings date, dividend rate and dividend yield;
Analyst Predictions: stock forecast and analyst ratings;
Analysis: Finny Score and buy or sell analysis;
Key Stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio, industry, sector, and number of employees.

And here is the list of questions we'll answer:
1. What are TNDM earnings?
2. What is TNDM stock forecast (i.e., prediction)?
3. TNDM buy or sell? What is TNDM Finny Score?
4. What are the reasons to buy TNDM? Why should I buy TNDM stock?
5. What are the reasons to sell TNDM? Why should I sell TNDM stock?
6. What are TNDM key stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

So let's start. Scroll down to the question that interests you the most.

Earnings and Dividends

1. What are TNDM earnings?

TNDM trailing 12-month earnings per share (EPS) is -$0.71.

Analyst Predictions

2. What is TNDM stock forecast (i.e., prediction)?

Based on TNDM analyst price targets, TNDM stock forecast is $120.47 (for a year from now). That means the average analyst price target for TNDM stock is $120.47. The prediction is based on 7 analyst estimates.

The low price target for TNDM is $97.00, while the high price target is $140.00.

TNDM analyst rating is Hold.

Analysis

3. TNDM buy or sell? What is TNDM Finny Score?

#{finnyScore:40}Our quantitative analysis shows 4 reasons to buy and 6 reasons to sell TNDM, resulting in Finny Score of 40.

4. What are the reasons to buy TNDM? Why should I buy TNDM stock?

Here are the reasons to buy TNDM stock:

  • TNDM quarterly revenue growth was 17.10%, higher than the industry and sector average revenue growth (1.50% and 0.83%, respectively). See TNDM revenue growth chart.
  • TNDM profitability is improving. The YoY profit margin change was 31.18 percentage points. See TNDM profitability chart.
  • TNDM average analyst price target ($120.47) is above its current price ($106.40). See TNDM price target chart.
  • TNDM cash to debt ratio is 1.92, higher than the average industry (0.18) and sector (0.16) cash to debt ratio. See TNDM cash to debt chart.

5. What are the reasons to sell TNDM? Why should I sell TNDM stock?

Let's look at the reasons to sell TNDM stock (i.e., the bear case):

Key Stats

6. What are TNDM key stats : revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

Let's look at the key statistics for TNDM:

Metrics TNDM
Price $116.50
Average Price Target / Upside $120.47 / 3.41%
Average Analyst Rating Hold
Forward Dividend Yield 0.00%
Industry Medical Devices
Sector Healthcare
Number of Employees 653
Market Cap $7.4B
Forward P/E Ratio 1,518.50
Price/Book Ratio 18.04
Revenue (TTM) $410.22M
YoY Quarterly Revenue Growth 17.10%
Profit Margin -10.29%

If you liked this analysis, check out Stock Guides for other stocks.

Follow Us